Metformin Hydrochlorid is an oral medicine used to treat cardiovascular diseases such as hypertension.
The “Metformin Hydrochlorid Industry Forecast” looks at past sales and reviews total world Metformin Hydrochlorid sales in 2022, providing a comprehensive analysis by region and market sector of projected Metformin Hydrochlorid sales for 2023 through 2029. With Metformin Hydrochlorid sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Metformin Hydrochlorid industry.
This Insight Report provides a comprehensive analysis of the global Metformin Hydrochlorid landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Metformin Hydrochlorid portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Metformin Hydrochlorid market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Metformin Hydrochlorid and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Metformin Hydrochlorid.
The global Metformin Hydrochlorid market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Metformin Hydrochlorid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Metformin Hydrochlorid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Metformin Hydrochlorid is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Metformin Hydrochlorid players cover Merck Group, 1A Pharma GmbH, STADAPHARM GmbH, ALIUD Pharma GmbH, Sumitomo Dainippon Pharma, Fusen Pharmaceutical Company Limited, Chengdu Hengrui Pharmaceutical Co., Ltd., Sihuan Pharmaceutical and Beijing Zhonghui Pharmaceutical Industry, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Metformin Hydrochlorid market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
0.25g
0.5g
0.85g
Segmentation by application
Hospital
Clinic
Pharmacy
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck Group
1A Pharma GmbH
STADAPHARM GmbH
ALIUD Pharma GmbH
Sumitomo Dainippon Pharma
Fusen Pharmaceutical Company Limited
Chengdu Hengrui Pharmaceutical Co., Ltd.
Sihuan Pharmaceutical
Beijing Zhonghui Pharmaceutical Industry
Youcare Pharmaceutical Group
China Associate (Group) Co., LTD
Shanghai Hengshan PharmaceuticalCoLtd
Tianan Pharmaceutical
Shanghai Sine Pharmaceutical Factory
Beijing Jingfeng Pharmaceutical Group Co., Ltd.
Hebei Tiancheng Pharmaceutical Co., Ltd
Shijiazhuang Yiling Pharmaceutical Co Ltd
Chongqing Conquer Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Metformin Hydrochlorid market?
What factors are driving Metformin Hydrochlorid market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Metformin Hydrochlorid market opportunities vary by end market size?
How does Metformin Hydrochlorid break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Metformin Hydrochlorid Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Metformin Hydrochlorid by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Metformin Hydrochlorid by Country/Region, 2018, 2022 & 2029
2.2 Metformin Hydrochlorid Segment by Type
2.2.1 0.25g
2.2.2 0.5g
2.2.3 0.85g
2.3 Metformin Hydrochlorid Sales by Type
2.3.1 Global Metformin Hydrochlorid Sales Market Share by Type (2018-2023)
2.3.2 Global Metformin Hydrochlorid Revenue and Market Share by Type (2018-2023)
2.3.3 Global Metformin Hydrochlorid Sale Price by Type (2018-2023)
2.4 Metformin Hydrochlorid Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Pharmacy
2.5 Metformin Hydrochlorid Sales by Application
2.5.1 Global Metformin Hydrochlorid Sale Market Share by Application (2018-2023)
2.5.2 Global Metformin Hydrochlorid Revenue and Market Share by Application (2018-2023)
2.5.3 Global Metformin Hydrochlorid Sale Price by Application (2018-2023)
3 Global Metformin Hydrochlorid by Company
3.1 Global Metformin Hydrochlorid Breakdown Data by Company
3.1.1 Global Metformin Hydrochlorid Annual Sales by Company (2018-2023)
3.1.2 Global Metformin Hydrochlorid Sales Market Share by Company (2018-2023)
3.2 Global Metformin Hydrochlorid Annual Revenue by Company (2018-2023)
3.2.1 Global Metformin Hydrochlorid Revenue by Company (2018-2023)
3.2.2 Global Metformin Hydrochlorid Revenue Market Share by Company (2018-2023)
3.3 Global Metformin Hydrochlorid Sale Price by Company
3.4 Key Manufacturers Metformin Hydrochlorid Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Metformin Hydrochlorid Product Location Distribution
3.4.2 Players Metformin Hydrochlorid Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Metformin Hydrochlorid by Geographic Region
4.1 World Historic Metformin Hydrochlorid Market Size by Geographic Region (2018-2023)
4.1.1 Global Metformin Hydrochlorid Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Metformin Hydrochlorid Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Metformin Hydrochlorid Market Size by Country/Region (2018-2023)
4.2.1 Global Metformin Hydrochlorid Annual Sales by Country/Region (2018-2023)
4.2.2 Global Metformin Hydrochlorid Annual Revenue by Country/Region (2018-2023)
4.3 Americas Metformin Hydrochlorid Sales Growth
4.4 APAC Metformin Hydrochlorid Sales Growth
4.5 Europe Metformin Hydrochlorid Sales Growth
4.6 Middle East & Africa Metformin Hydrochlorid Sales Growth
5 Americas
5.1 Americas Metformin Hydrochlorid Sales by Country
5.1.1 Americas Metformin Hydrochlorid Sales by Country (2018-2023)
5.1.2 Americas Metformin Hydrochlorid Revenue by Country (2018-2023)
5.2 Americas Metformin Hydrochlorid Sales by Type
5.3 Americas Metformin Hydrochlorid Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Metformin Hydrochlorid Sales by Region
6.1.1 APAC Metformin Hydrochlorid Sales by Region (2018-2023)
6.1.2 APAC Metformin Hydrochlorid Revenue by Region (2018-2023)
6.2 APAC Metformin Hydrochlorid Sales by Type
6.3 APAC Metformin Hydrochlorid Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Metformin Hydrochlorid by Country
7.1.1 Europe Metformin Hydrochlorid Sales by Country (2018-2023)
7.1.2 Europe Metformin Hydrochlorid Revenue by Country (2018-2023)
7.2 Europe Metformin Hydrochlorid Sales by Type
7.3 Europe Metformin Hydrochlorid Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Metformin Hydrochlorid by Country
8.1.1 Middle East & Africa Metformin Hydrochlorid Sales by Country (2018-2023)
8.1.2 Middle East & Africa Metformin Hydrochlorid Revenue by Country (2018-2023)
8.2 Middle East & Africa Metformin Hydrochlorid Sales by Type
8.3 Middle East & Africa Metformin Hydrochlorid Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Metformin Hydrochlorid
10.3 Manufacturing Process Analysis of Metformin Hydrochlorid
10.4 Industry Chain Structure of Metformin Hydrochlorid
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Metformin Hydrochlorid Distributors
11.3 Metformin Hydrochlorid Customer
12 World Forecast Review for Metformin Hydrochlorid by Geographic Region
12.1 Global Metformin Hydrochlorid Market Size Forecast by Region
12.1.1 Global Metformin Hydrochlorid Forecast by Region (2024-2029)
12.1.2 Global Metformin Hydrochlorid Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Metformin Hydrochlorid Forecast by Type
12.7 Global Metformin Hydrochlorid Forecast by Application
13 Key Players Analysis
13.1 Merck Group
13.1.1 Merck Group Company Information
13.1.2 Merck Group Metformin Hydrochlorid Product Portfolios and Specifications
13.1.3 Merck Group Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Merck Group Main Business Overview
13.1.5 Merck Group Latest Developments
13.2 1A Pharma GmbH
13.2.1 1A Pharma GmbH Company Information
13.2.2 1A Pharma GmbH Metformin Hydrochlorid Product Portfolios and Specifications
13.2.3 1A Pharma GmbH Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 1A Pharma GmbH Main Business Overview
13.2.5 1A Pharma GmbH Latest Developments
13.3 STADAPHARM GmbH
13.3.1 STADAPHARM GmbH Company Information
13.3.2 STADAPHARM GmbH Metformin Hydrochlorid Product Portfolios and Specifications
13.3.3 STADAPHARM GmbH Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 STADAPHARM GmbH Main Business Overview
13.3.5 STADAPHARM GmbH Latest Developments
13.4 ALIUD Pharma GmbH
13.4.1 ALIUD Pharma GmbH Company Information
13.4.2 ALIUD Pharma GmbH Metformin Hydrochlorid Product Portfolios and Specifications
13.4.3 ALIUD Pharma GmbH Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 ALIUD Pharma GmbH Main Business Overview
13.4.5 ALIUD Pharma GmbH Latest Developments
13.5 Sumitomo Dainippon Pharma
13.5.1 Sumitomo Dainippon Pharma Company Information
13.5.2 Sumitomo Dainippon Pharma Metformin Hydrochlorid Product Portfolios and Specifications
13.5.3 Sumitomo Dainippon Pharma Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Sumitomo Dainippon Pharma Main Business Overview
13.5.5 Sumitomo Dainippon Pharma Latest Developments
13.6 Fusen Pharmaceutical Company Limited
13.6.1 Fusen Pharmaceutical Company Limited Company Information
13.6.2 Fusen Pharmaceutical Company Limited Metformin Hydrochlorid Product Portfolios and Specifications
13.6.3 Fusen Pharmaceutical Company Limited Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Fusen Pharmaceutical Company Limited Main Business Overview
13.6.5 Fusen Pharmaceutical Company Limited Latest Developments
13.7 Chengdu Hengrui Pharmaceutical Co., Ltd.
13.7.1 Chengdu Hengrui Pharmaceutical Co., Ltd. Company Information
13.7.2 Chengdu Hengrui Pharmaceutical Co., Ltd. Metformin Hydrochlorid Product Portfolios and Specifications
13.7.3 Chengdu Hengrui Pharmaceutical Co., Ltd. Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Chengdu Hengrui Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Chengdu Hengrui Pharmaceutical Co., Ltd. Latest Developments
13.8 Sihuan Pharmaceutical
13.8.1 Sihuan Pharmaceutical Company Information
13.8.2 Sihuan Pharmaceutical Metformin Hydrochlorid Product Portfolios and Specifications
13.8.3 Sihuan Pharmaceutical Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Sihuan Pharmaceutical Main Business Overview
13.8.5 Sihuan Pharmaceutical Latest Developments
13.9 Beijing Zhonghui Pharmaceutical Industry
13.9.1 Beijing Zhonghui Pharmaceutical Industry Company Information
13.9.2 Beijing Zhonghui Pharmaceutical Industry Metformin Hydrochlorid Product Portfolios and Specifications
13.9.3 Beijing Zhonghui Pharmaceutical Industry Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Beijing Zhonghui Pharmaceutical Industry Main Business Overview
13.9.5 Beijing Zhonghui Pharmaceutical Industry Latest Developments
13.10 Youcare Pharmaceutical Group
13.10.1 Youcare Pharmaceutical Group Company Information
13.10.2 Youcare Pharmaceutical Group Metformin Hydrochlorid Product Portfolios and Specifications
13.10.3 Youcare Pharmaceutical Group Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Youcare Pharmaceutical Group Main Business Overview
13.10.5 Youcare Pharmaceutical Group Latest Developments
13.11 China Associate (Group) Co., LTD
13.11.1 China Associate (Group) Co., LTD Company Information
13.11.2 China Associate (Group) Co., LTD Metformin Hydrochlorid Product Portfolios and Specifications
13.11.3 China Associate (Group) Co., LTD Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 China Associate (Group) Co., LTD Main Business Overview
13.11.5 China Associate (Group) Co., LTD Latest Developments
13.12 Shanghai Hengshan PharmaceuticalCoLtd
13.12.1 Shanghai Hengshan PharmaceuticalCoLtd Company Information
13.12.2 Shanghai Hengshan PharmaceuticalCoLtd Metformin Hydrochlorid Product Portfolios and Specifications
13.12.3 Shanghai Hengshan PharmaceuticalCoLtd Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Shanghai Hengshan PharmaceuticalCoLtd Main Business Overview
13.12.5 Shanghai Hengshan PharmaceuticalCoLtd Latest Developments
13.13 Tianan Pharmaceutical
13.13.1 Tianan Pharmaceutical Company Information
13.13.2 Tianan Pharmaceutical Metformin Hydrochlorid Product Portfolios and Specifications
13.13.3 Tianan Pharmaceutical Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Tianan Pharmaceutical Main Business Overview
13.13.5 Tianan Pharmaceutical Latest Developments
13.14 Shanghai Sine Pharmaceutical Factory
13.14.1 Shanghai Sine Pharmaceutical Factory Company Information
13.14.2 Shanghai Sine Pharmaceutical Factory Metformin Hydrochlorid Product Portfolios and Specifications
13.14.3 Shanghai Sine Pharmaceutical Factory Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Shanghai Sine Pharmaceutical Factory Main Business Overview
13.14.5 Shanghai Sine Pharmaceutical Factory Latest Developments
13.15 Beijing Jingfeng Pharmaceutical Group Co., Ltd.
13.15.1 Beijing Jingfeng Pharmaceutical Group Co., Ltd. Company Information
13.15.2 Beijing Jingfeng Pharmaceutical Group Co., Ltd. Metformin Hydrochlorid Product Portfolios and Specifications
13.15.3 Beijing Jingfeng Pharmaceutical Group Co., Ltd. Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Beijing Jingfeng Pharmaceutical Group Co., Ltd. Main Business Overview
13.15.5 Beijing Jingfeng Pharmaceutical Group Co., Ltd. Latest Developments
13.16 Hebei Tiancheng Pharmaceutical Co., Ltd
13.16.1 Hebei Tiancheng Pharmaceutical Co., Ltd Company Information
13.16.2 Hebei Tiancheng Pharmaceutical Co., Ltd Metformin Hydrochlorid Product Portfolios and Specifications
13.16.3 Hebei Tiancheng Pharmaceutical Co., Ltd Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Hebei Tiancheng Pharmaceutical Co., Ltd Main Business Overview
13.16.5 Hebei Tiancheng Pharmaceutical Co., Ltd Latest Developments
13.17 Shijiazhuang Yiling Pharmaceutical Co Ltd
13.17.1 Shijiazhuang Yiling Pharmaceutical Co Ltd Company Information
13.17.2 Shijiazhuang Yiling Pharmaceutical Co Ltd Metformin Hydrochlorid Product Portfolios and Specifications
13.17.3 Shijiazhuang Yiling Pharmaceutical Co Ltd Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 Shijiazhuang Yiling Pharmaceutical Co Ltd Main Business Overview
13.17.5 Shijiazhuang Yiling Pharmaceutical Co Ltd Latest Developments
13.18 Chongqing Conquer Pharmaceutical Co., Ltd.
13.18.1 Chongqing Conquer Pharmaceutical Co., Ltd. Company Information
13.18.2 Chongqing Conquer Pharmaceutical Co., Ltd. Metformin Hydrochlorid Product Portfolios and Specifications
13.18.3 Chongqing Conquer Pharmaceutical Co., Ltd. Metformin Hydrochlorid Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Chongqing Conquer Pharmaceutical Co., Ltd. Main Business Overview
13.18.5 Chongqing Conquer Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion
*If Applicable.